The $36.7 billion analytical and life science instrumentation industry is a dynamic business focused on the critical needs of society by providing important support to the development of disease fighting drugs and advanced materials, as well as safeguarding the environment and national security. Over the last fifty years, the industry has grown to include hundreds of firms developing and marketing a plethora of instrument techniques and assays based on a myriad of both old and new technologies.
It is also important to recognize that the industry is not only based on instrument systems, but also reagents, consumables and services that support instrument operation, as well as preparations and assays in kit form that provide test results without the need for additional hardware.
It goes without saying that the industry addresses a global market because the requirements for analysis is a worldwide phenomena, and industry participants can be found in many regions of the world. Having said this, it is also important to note that the major industrialized countries in North American, Europe and Japan represent over 80% of the current global market. However, growth is now focused on the developing regions, especially China and the Asia-Pacific region.
“ALSSA meetings and events provide me with the opportunity to develop and strengthen key relationships with senior industry executives and to also connect with emerging and start up companies in our industry.”